H.Amdt.974 to H.R.4461106th Congress (1999-2000)
Description: H.Amdt. 974 — 106th Congress (1999-2000)All Information (Except Text)
As of 10/16/2018 the description for this amendment has not been received.
An amendment numbered 32 printed in the Congressional Record to require, upon FDA approval of a new drug, the disclosure of the taxpayer funded contribution to the total cost of research and development of said drug.
House Amendment Code:
House Tally Clerks use this code to manage amendment information.